Vitamin E therapy in Parkinson's disease

By Fariss M.W.   Zhang J.-G.  

Toxicology, Vol. 189, Iss. 1, 2003-07 ,pp. : 129-146

Elsevier

Access to resources Recommend Favorite

Mitochondrial complex I inhibitor rotenone-induced toxicity and its potential mechanisms in Parkinson’s disease models

By Xiong Nian   Long Xi   Xiong Jing   Jia Min   Chen Chunnuan   Huang Jinsha   Ghoorah Devina   Kong Xiangquan   Lin Zhicheng   Wang Tao  

Critical Reviews in Toxicology, Vol. 42, Iss. 7, 2012-08 ,pp. : 613-632

Informa Healthcare

Access to resources Recommend Favorite

Deprenyl protects from MPTP-induced Parkinson-like syndrome and glutathione oxidation in rat striatum

By Leret M.L.   San Millan J.A.   Fabre E.   Gredilla R.   Barja G.  

Toxicology, Vol. 170, Iss. 3, 2002-01 ,pp. : 165-171

Elsevier

Access to resources Recommend Favorite

Environmental Exposures and Parkinson’s Disease

By Nandipati Sirisha   Litvan Irene  

International Journal of Environmental Research and Public Health, Vol. 13, Iss. 9, 2016-09 ,pp. : 881-881

MDPI

Access to resources Recommend Favorite

Overexpression of the Anti-apoptotic Oncogene, bcl-2, in the Thymus Does Not Prevent Thymic Atrophy Induced by Estradiol or 2,3,7,8-Tetrachlorodibenzo-p-Dioxin

By Staples J.E.   Fiore N.C.   Frazier D.E.   Gasiewicz T.A.   Silverstone A.E.  

Toxicology and Applied Pharmacology, Vol. 151, Iss. 1, 1998-07 ,pp. : 200-210

Elsevier

Access to resources Recommend Favorite